171 related articles for article (PubMed ID: 15870869)
1. Cutaneous CD56 positive natural killer and cytotoxic T-cell lymphomas.
Chattopadhyay A; Slater DN; Hancock BW
Int J Oncol; 2005 Jun; 26(6):1559-62. PubMed ID: 15870869
[TBL] [Abstract][Full Text] [Related]
2. Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK.
Child FJ; Mitchell TJ; Whittaker SJ; Calonje E; Spittle M; Crocker J; Russell-Jones R
Br J Dermatol; 2003 Mar; 148(3):507-15. PubMed ID: 12653743
[TBL] [Abstract][Full Text] [Related]
3. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
4. New CD56 positive and cytotoxic T-cell cutaneous lymphomas from the World Health Organisation.
Slater DN
Br J Dermatol; 2003 Mar; 148(3):385-7. PubMed ID: 12653728
[No Abstract] [Full Text] [Related]
5. Clinicopathologic differences between 22 cases of CD56-negative and CD56-positive subcutaneous panniculitis-like lymphoma in Japan.
Takeshita M; Okamura S; Oshiro Y; Imayama S; Okamoto S; Matsuki Y; Nakashima Y; Okamura T; Shiratsuchi M; Hayashi T; Kikuchi M
Hum Pathol; 2004 Feb; 35(2):231-9. PubMed ID: 14991542
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic gamma/delta subcutaneous panniculitis-like T-cell lymphoma: report of a case with pulmonary involvement unresponsive to therapy.
Guizzardi M; Hendrickx IA; Mancini LL; Monti M
J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):219-22. PubMed ID: 12705758
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
[TBL] [Abstract][Full Text] [Related]
8. CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC).
Petrella T; Dalac S; Maynadié M; Mugneret F; Thomine E; Courville P; Joly P; Lenormand B; Arnould L; Wechsler J; Bagot M; Rieux C; Bosq J; Avril MF; Bernheim A; Molina T; Devidas A; Delfau-Larue MH; Gaulard P; Lambert D
Am J Surg Pathol; 1999 Feb; 23(2):137-46. PubMed ID: 9989839
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous natural killer/T-cell lymphoma.
Radonich MA; Lazova R; Bolognia J
J Am Acad Dermatol; 2002 Mar; 46(3):451-6. PubMed ID: 11862188
[TBL] [Abstract][Full Text] [Related]
10. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype.
Dukers DF; Vermeer MH; Jaspars LH; Sander CA; Flaig MJ; Vos W; Willemze R; Meijer CJ
J Clin Pathol; 2001 Mar; 54(3):224-8. PubMed ID: 11253136
[TBL] [Abstract][Full Text] [Related]
11. A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature.
Kameoka J; Ichinohasama R; Tanaka M; Miura I; Tomiya Y; Takahashi S; Yamada M; Ishikawa I; Kadowaki I; Sasaki O; Kimura J; Meguro K; Ooya K; Ito S
Am J Clin Pathol; 1998 Oct; 110(4):478-88. PubMed ID: 9763034
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients.
Hoque SR; Child FJ; Whittaker SJ; Ferreira S; Orchard G; Jenner K; Spittle M; Russell-Jones R
Br J Dermatol; 2003 Mar; 148(3):516-25. PubMed ID: 12653744
[TBL] [Abstract][Full Text] [Related]
13. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature.
Bekkenk MW; Jansen PM; Meijer CJ; Willemze R
Ann Oncol; 2004 Jul; 15(7):1097-108. PubMed ID: 15205205
[TBL] [Abstract][Full Text] [Related]
14. CD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement.
Lan MX; Zhen ZX; Ming WH
Leuk Lymphoma; 2009 Oct; 50(10):1715-7. PubMed ID: 19863343
[No Abstract] [Full Text] [Related]
15. Blastic CD56+ natural killer-cell lymphoma with primary cutaneous manifestation.
Berger TG; Voll RE; Simon M; Kiesewetter F
Acta Derm Venereol; 2004; 84(1):53-6. PubMed ID: 15040479
[TBL] [Abstract][Full Text] [Related]
16. A case of CD4+/CD56+ hematodermic neoplasm (plasmacytoid dendritic cell neoplasm).
Su O; Onsun N; Demirkesen C; Aydin Y; Pirmit S; Gereli M
Dermatol Online J; 2010 Apr; 16(4):8. PubMed ID: 20409415
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous CD8+ cytotoxic T-cell lymphoma involving the epidermis and subcutis in a young child.
Wang L; Gao T; Wang G
J Cutan Pathol; 2015 Apr; 42(4):271-5. PubMed ID: 25458991
[TBL] [Abstract][Full Text] [Related]
18. [Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases].
Machet L; De Muret A; Wiezberka E; Bernez A; Abdallah-Lotf M; Linassier C; Petrella T
Ann Dermatol Venereol; 2004 Nov; 131(11):969-73. PubMed ID: 15602384
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous natural killer (NK) / T-cell lymphoma: nasal type with extensive facial destruction.
Kost Al M; Kost Alová M; Belada D; Laco J
Int J Dermatol; 2009 Dec; 48(12):1338-42. PubMed ID: 19930492
[No Abstract] [Full Text] [Related]
20. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
